BIOMAT Database Logo BIOMAT Database Logo

New semisynthetic antitumor antibiotics, SF-1739 HP and naphthocyanidine. 1982

J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
[Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives].
July 1977, Antibiotiki,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
Antitumor activity of new semisynthetic saframycin derivatives.
October 1986, Japanese journal of cancer research : Gann,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
[Semisynthetic antibiotics].
August 1982, Voenno-meditsinskii zhurnal,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
[Semisynthetic antibiotics].
February 1984, Fel'dsher i akusherka,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
New anthracycline antitumor antibiotics.
January 1991, Critical reviews in oncology/hematology,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
Gilvocarcins, new antitumor antibiotics. 3. Antitumor activity.
June 1981, The Journal of antibiotics,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
[New antitumor antibiotics 5590 and 2928].
July 1981, Antibiotiki,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
Semisynthetic aminoglycoside antibiotics. III. New deoxy derivatives of paromomycin.
February 1981, The Journal of antibiotics,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
January 1987, The Journal of antibiotics,
J Itoh, and S Omoto, and S Inouye, and Y Kodama, and T Hisamatsu, and T Niida, and Y Ogawa
New antitumor antibiotics aclacinomycins A and B.
October 1975, The Journal of antibiotics,
Copied contents to your clipboard!